Good morning :)
Switch to
Place Order

Caplin Point Laboratories Ltd

CAPLIPOINT
Health CarePharmaceuticals
SmallcapWith a market cap of ₹4,940 cr, stock is ranked 446
Moderate RiskStock is 2.74x as volatile as Nifty
653.2015.55 (-2.33%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹4,940 cr, stock is ranked 446
Moderate RiskStock is 2.74x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
20.39
PB RatioPB Ratio
5.17
Dividend YieldDiv. Yield
0.23%
Sector PESector PE
37.87
Sector PBSector PB
5.67
Sector Div YldSctr Div Yld
0.66%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Caplin Point Laboratories Limited is a pharmaceutical company. The Company's product segments include Antibiotics, Non-steroidal anti-inflammatory drugs (NSAIDS), Ophthalmics, Pain Management and Anti-ulcers.

Investor PresentationView older 

Aug 11, 2020

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20182019202020210.550.670.901.080.140.180.220.24
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Related Party Transactions 
Announced OnJun 4, 2021

Caplin Point Laboratories Limited has informed the Exchange about related Party Transactions | Download

Caplin Point Laboratories Limited has informed the Exchange about related Party Transactions | Download

Reply to Clarification Sought 
Announced OnJun 2, 2021

CAPLIPOINT: The Exchange had sought clarification from Caplin Point Laboratories Limited with respect to announcement dated 06-May-2021, regarding outcome of its Board meeting held on 06-May-2021. On basis of above the Company was required to clarify following:ᅡᅠ1. Brief details of any governmental or regulatory approvals required for the acquisition;2. Cost of acquisition or the price at which the shares are acquired;3. Nature of consideration - whether cash consideration or share swap and details of the same;The response of the Company is attached. | Download

CAPLIPOINT: The Exchange had sought clarification from Caplin Point Laboratories Limited with respect to announcement dated 06-May-2021, regarding outcome of its Board meeting held on 06-May-2021. On basis of above the Company was required to clarify following:ᅡᅠ1. Brief details of any governmental or regulatory approvals required for the acquisition;2. Cost of acquisition or the price at which the shares are acquired;3. Nature of consideration - whether cash consideration or share swap and details of the same;The response of the Company is attached. | Download

Cash Dividend 
Ex. DateMay 18, 2021

Interim • Div/Share: ₹ 1.5

See all events